Backward: Hydroxypioglitazone or MIV (146062-44-4)

Hydroxypioglitazone
Hydroxypioglitazone or MIV

Catalog Selection !
  • ..:: Product Name (search) ::..
  • ..:: CAS No. (search) ::..
  • ..:: Alphabetical (filter) ::..

Hydroxypioglitazone
or M-IV
or Hydroxypioglitazone
or MIV

CAS Number: 146062-44-4
Product Number: C1404
Family: Metabolites
Molecular Formula: C19H20N2O4S
Molecular Weight: 372.44 g.mol-1
Catalog Quantity: 1 mg, 10 mg, 100 mg,

Hydroxypioglitazone or MIV (146062-44-4)

Hydroxypioglitazone or MIV (146062-44-4)
Hydroxypioglitazone or MIV (146062-44-4)
Hydroxypioglitazone or MIV (CAS: 146062-44-4) - Hydroxypioglitazone or M-IV

Related Compounds: Browse Pioglitazone collection here !
Pioglitazone hydrochloride

Pioglitazone (112529-15-4)
[13C,2H3]-Pioglitazone

Pioglitazone-13C-D3 (111025-46-8 unlabeled)
[2H4]-Pioglitazone

Pioglitazone-D4 (1134163-29-3)
[2H4]-Hydroxypioglitazone

Hydroxypioglitazone-D4 (1188263-49-1)
Hydroxypioglitazone

Hydroxypioglitazone_or_MIV (146062-44-4)
Pioglitazone ketone

Pioglitazone_ketone (146062-45-5)
[2H4]-Pioglitazone ketone

Pioglitazone_ketone-D4 (1215370-26-5)

Keywords : Internal standard, Internal standard Hydroxypioglitazone or MIV, HPLC-MS method validation, HPLC-MS method validation Hydroxypioglitazone or MIV, LC-MS-MS method validation, LC-MS-MS method validation Hydroxypioglitazone or MIV, Deuterated internal standard, Deuterated internal standard Hydroxypioglitazone or MIV, Deuterated Hydroxypioglitazone or MIV, Deuterium labeled Hydroxypioglitazone or MIV, Quantitative bioanalytical methods, Quantitative bioanalytical methods Hydroxypioglitazone or MIV, Blood samples Hydroxypioglitazone or MIV, Blood concentrations, Heavy drugs, Analysis, Analysis Hydroxypioglitazone or MIV, Clinical diagnostic, Clinical diagnostic Hydroxypioglitazone or MIV, Dosing Hydroxypioglitazone or MIV, Analytical method development, Internal standard method.

If you find that a product is not part of our current offering,
we strongly encourage you to place a request for a quotation nonetheless.